Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management.

Holland, David; Heald, Adrian H.; Stedman, Mike; Green, Lewis; Scargill, Jonathan; Wu, Pensee; Duff, Christopher J.; Hanna, Fahmy W.F.; Halsall, Ian; Gaskell, Neil; Fryer, Anthony A.

doi:10.1111/ijcp.13980

Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management.

Holland, David; Heald, Adrian H.; Stedman, Mike; Green, Lewis; Scargill, Jonathan; Wu, Pensee; Duff, Christopher J.; Hanna, Fahmy W.F.; Halsall, Ian; Gaskell, Neil; Fryer, Anthony A.

Authors

David Holland

Adrian H. Heald

Mike Stedman

Lewis Green

Jonathan Scargill

Pensee Wu p.wu@keele.ac.uk

Christopher J. Duff

Fahmy W.F. Hanna

Ian Halsall

Neil Gaskell

Professor Anthony Fryer a.a.fryer@keele.ac.uk

Citation

Holland, D., Heald, A. H., Stedman, M., Green, L., Scargill, J., Wu, P., …Fryer, A. A. (2021). Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management. International Journal of Clinical Practice, 75, https://doi.org/10.1111/ijcp.13980

Journal Article Type	Letter
Acceptance Date	Mar 19, 2021
Online Publication Date	Mar 19, 2021
Publication Date	Apr 1, 2021
Journal	International journal of clinical practice
Print ISSN	1368-5031
Publisher	Wiley
Peer Reviewed	Peer Reviewed
Volume	75
DOI	https://doi.org/10.1111/ijcp.13980
Publisher URL	https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13980
PMID	33752297